(Q1169164)

BENDROFLUMETHIAZIDE (English)

3 October 2016

chemical formula

C₁₅H₁₄F₃N₃O₄S₂

1 reference

BENDROFLUMETHIAZIDE (English)

19 November 2016

canonical SMILES

C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2

1 reference

BENDROFLUMETHIAZIDE (English)

https://www.whocc.no/atc_ddd_index/?code=C03AA01

19 November 2016

defined daily dose

2.5 milligram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

bendroflumethiazide (English)

1 reference

bendroflumethiazide (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

13 December 2016

arterial hypertension

1 reference

13 December 2016

congestive heart failure

1 reference

Food and Drug Administration

13 December 2016

arterial hypertension

start time

25 May 1983

approved by

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/5Q52X6ICJI

2 November 2018

reference URL

http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018647s025lbl.pdf

significant drug interaction

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lithium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosinopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosinopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vomiting

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nausea

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

hypomagnesemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

solute carrier family 12 member 3

subject has role

reaction inhibitor

1 reference

Open _targets Platform

https://platform.open_targets.org/drug/CHEMBL1684

14 August 2023

reference URL

legal status (medicine)

prescription drug

applies to jurisdiction

United Kingdom

0 references

subject has role

antihypertensive drug

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D001539

Sodium Chloride Symporter Inhibitors

15 March 2018

1 reference

InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23)

Medical Subject Headings

15 March 2018

Bendroflumethiazide

0 references

Identifiers

InChI

1 reference

BENDROFLUMETHIAZIDE (English)

19 November 2016

2 references

BENDROFLUMETHIAZIDE (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

73-48-3

2 references

bendroflumethiazide (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=73-48-3

8 April 2021

1 reference

bendroflumethiazide (English)

19 November 2016

2 references

BENDROFLUMETHIAZIDE (English)

19 November 2016

Reaxys registry number

373316

1 reference

bendroflumethiazide (English)

3 October 2016

ChEBI ID

3013

mapping relation type

2 references

BENDROFLUMETHIAZIDE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23)

1 reference

BENDROFLUMETHIAZIDE (English)

19 November 2016

2 references

inferred from InChIKey

1 reference

MassBank accession ID

MSBNK-Waters-WA001805

0 references

MSBNK-Waters-WA001806

0 references

MSBNK-Waters-WA001807

0 references

MSBNK-Waters-WA001808

0 references

MSBNK-Waters-WA001809

0 references

HSDB ID

3293

1 reference

Hazardous Substances Data Bank

28 October 2019

BENDROFLUMETHIAZIDE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

bendroflumethiazide (English)

ECHA Substance Infocard ID

19 November 2016

100.000.728

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.000.728

27 December 2018

Bendroflumethiazide (English)

quotation

CAS no.: 73-48-3 (English)

1 reference

Guide to Pharmacology Ligand ID

Bendroflumethiazide (English)

publication date

17 November 2015

7122

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7122

bendroflumethiazide (English)

19 November 2016

Bendroflumethiazide

0 references

MeSH tree code

D02.886.590.700.135.138

0 references

0 references

0 references

1 reference

bendroflumethiazide (English)

19 November 2016

DrugBank ID

DB00436

1 reference

Human Metabolome Database ID

HMDB0014580

2 references

based on heuristic

inferred from InChIKey

2 references

bendroflumethiazide (English)

19 November 2016

PatientsLikeMe treatment ID

0 references

1 reference

bendroflumethiazide (English)

19 November 2016

0 references

1 reference

1 reference

bendroflumethiazide (English)

3 October 2016

1 reference

bendroflumethiazide (English)

3 October 2016

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

bendroflumethiazide (English)